Using CabR variants established from MCF7 breast cancer cells, Duran et al. demonstrated a decrease in BRCA1 protein expression and induction of EMT thus validating our results (Fig 3) and linking EMT to CabR in both breast and prostate cancer [35]. This evidence concerns the gene BRCA1 and breast carcinoma.